US21867A1051
US21867A1051
Core Laboratories Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 462.98M EUR | 534.55M EUR | 773.15M EUR | 738.91M EUR |
Enterprise Value | 614.67M EUR | 676.93M EUR | 918.17M EUR | 880.23M EUR |
Valuation Multiples | ||||
Trailing P/E | 19.4x | 21.95x | 26.63x | 24.78x |
Forward P/E | 14.62x | -- | -- | -- |
Price to Sales | 0.89x | 1.03x | 1.47x | 1.83x |
Price to Book | 1.7x | 1.96x | 2.88x | 2.78x |
EV/Revenue | 1.18x | 1.3x | 1.75x | 2.18x |
EV/EBITDA | 10.76x | 12x | 15.35x | 16.26x |
Price to FCF (P/FCF) | 12.86x | 49.81x | 42.28x | 38.46x |
EV/FCF | 17.07x | 63.08x | 50.21x | 45.82x |
FCF Yield | 7.78% | 2.01% | 2.36% | 2.6% |